Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Satraplatin and Paclitaxel in Advanced NSCLC
NCT00268970Phase 2Completed
- Sponsor
- Agennix AG
- Start
- Dec 2005
- Primary completion
- Apr 2007
- Countries
- 1
01
Overview
A Phase 2 trial of satraplatin in non-small cell lung cancer (NSCLC), sponsored by Agennix AG. Started Dec 2005; status: completed.
02
Drugs
satraplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00268970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00268970.